Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.

Paquette RL, Nicoll J, Chalukya M, Gondek L, Jasek M, Sawyers CL, Shah NP, Maciejewski J.

Leuk Res. 2010 Jun;34(6):708-13. doi: 10.1016/j.leukres.2009.08.032. Epub 2009 Oct 4.

PMID:
19804904
2.
3.

Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.

Larsson N, Billström R, Lilljebjörn H, Lassen C, Richter J, Ekblom M, Fioretos T.

Cancer Genet Cytogenet. 2010 Jun;199(2):89-95. doi: 10.1016/j.cancergencyto.2010.02.005.

PMID:
20471511
4.

Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure.

Fabarius A, Haferlach C, Müller MC, Erben P, Lahaye T, Giehl M, Frank O, Seifarth W, Hehlmann R, Hochhaus A.

Haematologica. 2007 Jun;92(6):834-7.

5.

Preclinical and clinical experience with dasatinib in Philadelphia chromosome-negative leukemias and myeloid disorders.

Verstovsek S.

Leuk Res. 2009 May;33(5):617-23. doi: 10.1016/j.leukres.2008.10.001. Epub 2008 Nov 14. Review.

6.

Philadelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia.

De Melo VA, Milojkovic D, Khorashad JS, Marin D, Goldman JM, Apperley JF, Reid AG.

Blood. 2007 Oct 15;110(8):3086-7. No abstract available.

7.

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.

Bumm T, Müller C, Al-Ali HK, Krohn K, Shepherd P, Schmidt E, Leiblein S, Franke C, Hennig E, Friedrich T, Krahl R, Niederwieser D, Deininger MW.

Blood. 2003 Mar 1;101(5):1941-9. Epub 2002 Oct 31.

8.

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.

Deininger MW, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M, Stone R, Fischer T, Kantarjian H, Niederwieser D, Gambacorti-Passerini C, So C, Gathmann I, Goldman JM, Smith D, Druker BJ, Guilhot F.

Cancer. 2007 Oct 1;110(7):1509-19.

10.

Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case.

Mozziconacci MJ, Caillères S, Maurice C, Vey N, Sainty D, Blaise D, Lafage-Pochitaloff M.

Leukemia. 2003 Sep;17(9):1901-2. No abstract available.

PMID:
12970792
11.

The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia.

Wakim JJ, Tirado CA, Dowell J, Chen W.

Cancer Genet. 2012 Mar;205(3):124-7. doi: 10.1016/j.cancergen.2012.01.006.

PMID:
22469511
12.

Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.

Lin Y, Bruyère H, Horsman DE, Pantzar T, Barnett MJ, Hogge DE, Nevill TJ, Nantel SH, Sutherland HJ, Toze CL, Shepherd JD, Lavoie JC, Song KW, Smith CA, Forrest DL.

Cancer Genet Cytogenet. 2006 Oct 1;170(1):16-23.

PMID:
16965950
13.

Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha.

Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T, Schoch C.

Leukemia. 2005 Mar;19(3):460-3. No abstract available.

PMID:
15625554
14.

Extensive cytogenetic studies of clonality following interferon-alpha therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic.

Takeshita A, Shinjo K, Yamashita M, Fujisawa S, Naito K, Ohnishi K, Takahashi K, Matsui H, Ohno R.

Leukemia. 1999 Nov;13(11):1749-53.

PMID:
10557048
15.

Clonal chromosomal abnormalities in Philadelphia-negative cells in chronic myeloid leukemia patients treated with nilotinib used in first-line therapy.

Wang H, Jin J, Wang Y, Huang X, Huang J.

Ann Hematol. 2013 Dec;92(12):1625-32. doi: 10.1007/s00277-013-1816-z. Epub 2013 Jun 23.

PMID:
23793947
16.
17.

Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.

Terre C, Eclache V, Rousselot P, Imbert M, Charrin C, Gervais C, Mozziconacci MJ, Maarek O, Mossafa H, Auger N, Dastugue N, Talmant P, Van den Akker J, Leonard C, N'Guyen Khac F, Mugneret F, Viguié F, Lafage-Pochitaloff M, Bastie JN, Roux GL, Nicolini F, Maloisel F, Vey N, Laurent G, Recher C, Vigier M, Yacouben Y, Giraudier S, Vernant JP, Salles B, Roussi J, Castaigne S, Leymarie V, Flandrin G, Lessard M; France Intergroupe pour la Leucemie Myeloide Chronique.

Leukemia. 2004 Aug;18(8):1340-6.

PMID:
15190256
18.

Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under-reported and does it have any clinical significance?

O'Shea D, Crotty G, Carroll P, Conneally E, McCann S, Neat MJ.

Br J Haematol. 2004 Nov;127(3):367-9. No abstract available.

PMID:
15491304
19.

Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

O'Dwyer ME, Gatter KM, Loriaux M, Druker BJ, Olson SB, Magenis RE, Lawce H, Mauro MJ, Maziarz RT, Braziel RM.

Leukemia. 2003 Mar;17(3):481-7.

PMID:
12646934
20.

Novel chromosomal aberration in Philadelphia negative cells of a patient with chronic myelogenous leukemia treated with dasatinib.

Athanasiadou A, Lalayanni C, Papaioannou G, Gaitatzi M, Fassas A, Anagnostopoulos A.

Leuk Lymphoma. 2008 May;49(5):1012-3. doi: 10.1080/10428190801975543. No abstract available.

PMID:
18464124

Supplemental Content

Support Center